RaySearch Laboratories AB (publ) announces that the proton therapy machine vendor Ion Beam Applications S.A. (IBA), has placed an order for RayStation®* treatment planning system and the oncology information system RayCare®* to be installed at nine proton centers in Spain. RaySearch participated in the public tender in partnership with IBA, which is the main system integrator. Total order value is EUR 17.3 million of which EUR 14.9 million is for software licenses.
In 2021, the Spanish Ministry of Health and the Amancio Ortega Foundation signed an agreement under which the Foundation donated EUR 280 million to the Ministry of Health for the purchase of 10 proton therapy units, in nine centers, to be installed across the country. The publich tender was launched in July 2022 and included three rounds to choose the companies eligible of providing proton therapy equipment to the Spanish National Health System.
The order includes both RayStation and RayCare at all centers. The combination of RayStation and RayCare, together with an IBA proton therapy machine, provides an integrated and unified solution throughout the complete workflow.
Johan Löf, founder and CEO, RaySearch, says: “We are proud to supply both RayStation and RayCare to this extensive investment in proton therapy in Spain. For RaySearch, this means a further strengthening of our leading position in treatment planning for protons as well as a significant increase of our customer base for RayCare. The fact that all centers will use both RaySearch products will bring many synergies, both in terms of implementation and clinical practice of radiation therapy in Spain.”
The order value of EUR 17.3 million (corresponding to approximately SEK 188 million) is the largest ever for RaySearch. Delivery is expected to start in 2024 and will take place over several years. Service contract is excluded in the initial order but is expected to be added at the time of delievery.
This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 03:55 pm CET on December 9, 2022.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 800 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
About RayCare
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
Henrik Bergentoft, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
henrik.bergentoft@raysearchlabs.com